Literature DB >> 7114842

Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents.

R Vanhoof, H Goossens, H Coignau, G Stas, J P Butzler.   

Abstract

The in vitro antimicrobial activities of different antimicrobial agents on Campylobacter jejuni from human and animal origins were compared by using a Dynatech MIC 2000 system. In general, the minimal inhibitory concentration distributions for the human strains were very comparable with those of the animal strains. The animal strains had a bimodal distribution for ampicillin, clindamycin, and tetracycline.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114842      PMCID: PMC182058          DOI: 10.1128/AAC.21.6.990

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  Acute enteritis due to related vibrio: first positive stool cultures.

Authors:  P Dekeyser; M Gossuin-Detrain; J P Butzler; J Sternon
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Campylobacter serotyping a epidemiology.

Authors:  S Lauwers; L Vlaes; J P Butzler
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

4.  Transmissible drug resistance of Escherichia coli and Salmonella from humans, animals, and their rural environments.

Authors:  F J Marsik; J T Parisi; D C Blenden
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

5.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

6.  Campylobacter enteritis.

Authors:  M A Karmali; P C Fleming
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

7.  Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.

Authors:  M A Karmali; S De Grandis; P C Fleming
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

8.  Reservoirs for human campylobacteriosis.

Authors:  M J Blaser; F M LaForce; N A Wilson; W L Wang
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

9.  Transmissible plasmids from Campylobacter jejuni.

Authors:  D E Taylor; S A De Grandis; M A Karmali; P C Fleming
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

10.  Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.

Authors:  R Vanhoof; B Gordts; R Dierickx; H Coignau; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more
  16 in total

1.  Campylobacter enteritis in Portugal: epidemiological features and biological markers.

Authors:  J Cabrita; I Pires; L Vlaes; H Coignau; J Levy; H Goossens; A P Goncalves; P de Mol; J P Butzler
Journal:  Eur J Epidemiol       Date:  1992-01       Impact factor: 8.082

2.  Effects of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis.

Authors:  G D Inglis; T A McAllister; H W Busz; L J Yanke; D W Morck; M E Olson; R R Read
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

3.  Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.

Authors:  J Michel; M Rogol; D Dickman
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

4.  Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates.

Authors:  H Sagara; A Mochizuki; N Okamura; R Nakaya
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

5.  Serotyping studies of Campylobacter from naturally colonized chickens.

Authors:  E Sjögren; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

6.  Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.

Authors:  H Hof; V Sticht-Groh
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

7.  The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Authors:  R Vanhoof; J M Hubrechts; E Roebben; H J Nyssen; E Nulens; J Leger; N De Schepper
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

8.  In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents.

Authors:  B M Flores; C L Fennell; K K Holmes; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

9.  Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

Authors:  H Goossens; P De Mol; H Coignau; J Levy; O Grados; G Ghysels; H Innocent; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

10.  Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds.

Authors:  Z Elharrif; F Mégraud; A M Marchand
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.